Surgery Partners, Inc. reaffirmed earnings guidance for the fiscal year ended December 31, 2021. For the period, the company expects revenue of 19% to 21% growth over 2020 results.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.32 USD | -0.40% | -3.56% | -17.76% |
07/05 | Sector Update: Health Care Stocks Advance in Late Afternoon Trading | MT |
07/05 | Surgery Partners Rises after Q1 Adjusted Earnings, Revenue Increase; 2024 Revenue Outlook Boosted | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.76% | 3.34B | |
-23.26% | 15.57B | |
-0.90% | 11.94B | |
+3.48% | 11.59B | |
+4.52% | 10.23B | |
-6.48% | 7.44B | |
+6.39% | 6.8B | |
+0.89% | 5.96B | |
-4.31% | 4.25B | |
+6.46% | 4.01B |
- Stock Market
- Equities
- SGRY Stock
- News Surgery Partners, Inc.
- Surgery Partners, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ended December 31, 2021